Gender Equality Plan
Gender Equality Plan (GEP)
PPi Consulting | 2025
Our Commitment
At PPi Consulting, we are committed to promoting gender equality across our institution.
This Gender Equality Plan (GEP) outlines our approach to creating a more inclusive, respectful, and fair environment for all staff.
The GEP is formally endorsed by our leadership and publicly available as part of our commitment to transparency and accountability.
Key Pillars of Our Plan
1. Dedicated Resources
- Appointment of a Gender Equality Officer to lead implementation.
- Creation of a Gender Equality Committee with diverse representation.
- Annual budget allocation to support equality initiatives.
2. Data Collection and Monitoring
- Collection and analysis of gender-disaggregated data on staff.
- Annual publication of a Gender Equality Report to track progress and identify areas for improvement.
3. Training and Awareness
- Unconscious bias training for leadership, HR, and recruitment panels.
- Workshops and seminars for staff on gender equality topics.
- Inclusion of equality training in onboarding for new staff.
Action Areas and Measures
1. Work-Life Balance and Organizational Culture
- Flexible working arrangements and remote work options.
- Improved parental leave policies for all genders.
- Childcare support for staff.
- Promotion of inclusive language and respectful communication across the institution.
2. Gender Balance in Leadership and Decision-Making
- Gender balance targets for leadership roles and decision-making bodies.
- Diverse and transparent nomination and election processes.
- Monitoring of representation across all levels of governance.
3. Gender Equality in Recruitment and Career Progression
- Use of inclusive, gender-neutral language in job advertisements.
- Balanced composition of recruitment and promotion panels.
- Fair and bias-aware performance evaluation processes.
- Mentorship and support for underrepresented groups in academic and professional tracks.
4. Integration of Gender in Research and Teaching
- Training on incorporating gender perspectives in research methodologies.
- Review of curricula to include gender-sensitive content across disciplines.
- Support for gender-related research through funding and recognition.
5. Measures Against Gender-Based Violence and Harassment
- Zero-tolerance policy on gender-based violence and sexual harassment.
- Clear, confidential reporting channels for all members of the institution.
- Support services for those affected, including counselling and legal guidance.
- Regular climate surveys to monitor safety and institutional culture.
Governance and Reporting
- Oversight by the Gender Equality Officer and Committee.
- Annual reviews and adjustments based on data and feedback.
- Full plan reviewed and updated every three years.
About This Plan
This Gender Equality Plan is aligned with the European Commission’s minimum requirements and national frameworks. It addresses:
- Formal publication and endorsement by top management
- Dedicated human and financial resources
- Gender-disaggregated data collection and monitoring
- Training and awareness initiatives
- Action across five key areas of institutional change
Together, we are working to create a fairer, more inclusive academic and professional community for everyone.
TESTIMONIALS
“With their depth of market access experience across the EU, Adam Barak and his team at PPi Healthcare are well-positioned to provide timely, insightful guidance on pricing and reimbursement. ProMetic’s global strategic launch plans involving ultra-orphan therapies, have been greatly enhanced by our collaboration with PPi.”
Kristine Dorward, Director, Marketing & Business Development, ProMetic Life Sciences Inc.
“I want to let you know that the feedback from my colleagues after your presentation was that they are impressed by the amount of information that you have gathered within the research within such a short period.”
Ramona Schmid, Global Market Access, Pricing and Reimbursement Manager, HRA Pharma
“I have worked with PPi on several projects and I will work with them again. The first project was a European pricing study for an orphan product. Having already completed one study with a competitor, I found the PPi team to be particularly insightful, having taken the time to completely understand this complex project.”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals
“Recently I completed an assessment to inform the collection of pharmacoeconomic data in a clinical study in the US and Europe. The team again were very insightful and we had unexpected value-added when we found a member of the PPi had been involved in the pricing and reimbursement activities relating to one of our comparables. Great team, great results!”
Thomas W. MacAllister JD, PhD, Vice President of R&D and General Counsel, Remedy Pharmaceuticals